10/17/2024 3:54 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024 3:21 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:24 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:27 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:30 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:33 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:18 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.
|
08/13/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024 3:51 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024 7:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:05 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024 10:25 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:20 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:48 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024 5:02 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024 9:18 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:41 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:33 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024 2:38 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024 10:01 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024 9:22 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
New “Trump” currency proposed in DC (Ad) After a massive run-up – tech stocks are crashing.
And as you’d suspect, the rich and powerful got out first.
Warren Buffett sold off 115 million shares of Apple last year. We’ve posted the full recording online, where you can view it free of charge, here. |
06/04/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 9:16 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 1:19 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 8:04 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 3:43 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 9:09 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 9:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024 9:31 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 3:45 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024 9:24 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024 9:29 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024 9:43 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 7:57 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 3:15 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024 9:38 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 10:03 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 9:32 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024 3:49 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 9:12 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 2:44 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024 9:54 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 10:57 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024 5:01 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Crypto Genius: 12,000% in 12 months? [Here’s how] (Ad) We are entering the final Trump Bump of our lives.
But the biggest returns will not be in the stock market. If I’m right about this (like I was before) a modest $900 investment… |
04/02/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |